Next Week: Exceptional Gathering of Executives at the Pharma CI+MR Conference in Tokyo, Japan

TOKYO, Japan - Nov. 19, 2018 - PRLog -- The excitement is building among industry elites as next week brings the 2018 Pharma CI + MR Asia Conference, the first-ever forum of its kind to partner competitive intelligence, market research, and commercial functions in the pharma, biotech, and medical devices space. This anticipated event takes place November 29-30 at the Westin Tokyo Hotel in Tokyo, Japan.

The two-day conference begins with a collection of innovative keynotes from notable companies such as Takeda, Celgene, Daichii Sankyo, and The Boston Consulting Group.

Here's just a preview of the topics:

·         Value Based Healthcare

·         Drivers for Improving Japanese Healthcare

·         Challenges and Opportunities for Pharma and Biotech

·         And more!

View the detailed agenda here: http://asia.pharmaciconference.com/agenda/

This is your call for engagement! Join your colleagues and learn how the combination of competitive intelligence and market research can be an effective tool toward the future of your industry.

Register HERE: http://asia.pharmaciconference.com/register/

The Pharma CI + MR Asia Conference & Exhibition features the participation of the world's top companies, including: Abbott Laboratories, Biogen, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Deallus Consulting, Eisai, Lifescience Dynamics, Merck, Pfizer, Seed Planning Inc., Shionogi, Takeda, Vetter Pharma, and more.

The Pharma CI + MR Asia Conference & Exhibition is part of the Best and Largest CONFERENCE SERIES for Competitive Intelligence and Market Research Executives in Pharma, Biotech, and Medical Devices for 10+ Years.

For more information, call +1-212-228-7974 or email info@pharmaciconference.com